Gliomagenesis and the Use of Neural Stem Cells in Brain Tumor Treatment

ISSN: 1875-5992 (Online)
ISSN: 1871-5206 (Print)

Volume 17, 14 Issues, 2017

Download PDF Flyer

Anti-Cancer Agents in Medicinal Chemistry

Formerly: Current Medicinal Chemistry - Anti-Cancer Agents

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 27th of 59 in Chemistry, Medicinal

Submit Abstracts Online Submit Manuscripts Online

Michelle Prudhomme
Institut de Chimie de Clermont-Ferrand
Université Clermont Auvergne

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 2.722
5 - Year: 2.849

Gliomagenesis and the Use of Neural Stem Cells in Brain Tumor Treatment

Anti-Cancer Agents in Medicinal Chemistry, 10(2): 121-130.

Author(s): Pragathi Achanta, Neda I. Sedora Roman and Alfredo Quinones-Hinojosa.

Affiliation: Brain Tumor Stem Cell Laboratory,Department of Neurosurgery, Johns Hopkins University, School of Medicine, CRB II, Room 247, 1550 Orleans Street, Baltimore, MD, 21231,USA.


The role of neural stem cells (NSCs) in both the physiological and pathological processes in the brain has been refined through recent studies within the neuro-oncological field. Alterations in NSC regulatory mechanisms may be fundamental for the development and progression of malignant gliomas. A subpopulation of cells within the tumor known as brain tumor stem cells (BTSCs) have been shown to share key properties with NSCs. The BTSC hypothesis has significantly contributed to a potential understanding as to why brain tumors hold such dismal prognosis. On the other hand, the normal NSCs possess the capacity to migrate extensively towards the tumor bulk as well as to lingering neoplastic regions of the brain. The tropism of NSCs towards brain tumors may provide an additional tool for the treatment of brain cancer. The creation of potential therapies through the use of NSCs has been studied and includes the delivery of gene products to specific locations of the central nervous system selectively targeting malignant brain tumor cells and maximizing the efficiency of their delivery. Here, the proposed mechanisms of how brain tumors emerge, the molecular pathways interrupted in NSC pathogenesis and the most recent preclinical results in the use of NSCs for glioma treatment are reviewed.


Neural stem cells, brain tumors, Gliomagenesis, Glioma treatment, brain tumor stem cells, cell migration.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 10
Issue Number: 2
First Page: 121
Last Page: 130
Page Count: 10
DOI: 10.2174/187152010790909290
Price: $58

Related Journals

Webmaster Contact: Copyright © 2016 Bentham Science